personnel change news from Stryker in which OP-1 is prominently mentioned. hope this indicates some aggressive marketing is in the works:
Wednesday August 22, 8:43 am Eastern Time
Press Release
SOURCE: Stryker Corporation
Stryker Announces Management Changes
KALAMAZOO, Mich., Aug. 22 /PRNewswire/ -- John W. Brown, Chairman,
President and Chief Executive Officer of Stryker
Corporation (NYSE: SYK - news) announced the following management changes
today:
Mr. James E. Kemler, President of Stryker Biotech, has been promoted to the position
of Vice President of Stryker Corporation
and Group President, Stryker Biotech, Spine and Trauma. Mr. Kemler joined Stryker
Biotech in 1995 as General Manager and
was promoted to President in 1996. Under his leadership, Stryker Biotech has made
significant progress in the development of the
OP-1 Implant(TM) (Stryker's patented recombinant human protein for inducing bone
formation) including the recent regulatory
approvals in Australia and Europe. Mr. Brown noted that the Company's fastest
growing implant businesses, Spine and Trauma,
will play a key role in the long-term success of Stryker's OP-1 Implant(TM).
Mr. Timothy J. Scannell, Executive Vice President of Stryker Endoscopy, has been
promoted to the position of Vice President and
General Manager, Stryker Biotech. Mr. Scannell joined the Stryker Endoscopy sales
force in 1990, progressed rapidly through the
sales leadership roles and is currently responsible for Sales, Marketing and Operations.
During this time, Stryker Endoscopy has
become one of the Company's fastest growing businesses. Mr. Brown noted that Mr.
Scannell's background and track record will
complement the outstanding team already in place at the Biotech Division as they launch
the OP-1 Implant(TM) in the Australian
and European markets.
Reporting to Mr. Kemler under the new organization structure will be Mr. Scannell,
Michael R. Mainelli, Jr., Vice President and
President, Stryker Spine, and Vivian Masson, President, Stryker Trauma.
Stryker develops, manufactures and markets specialty surgical and medical products,
including orthopaedic reconstructive, trauma,
spinal and craniomaxillofacial implants, powered surgical instruments, endoscopic
systems, patient care and handling equipment for
the global market, and provides outpatient physical therapy services in the United
States. |
